Diagnostic tests for hepatitis C: recent trends in electrochemical immunosensor and genosensor analysis

Carolina V Uliana1, Carla S Riccardi1, Hideko Yamanaka1

  • 1Carolina V Uliana, Department of Chemistry, Federal University of São Carlos, CP 676, São Carlos, SP 13565-905, Brazil.

Insights

Electrochemical biosensors offer a promising approach for detecting the hepatitis C virus (HCV). These rapid and sensitive devices can aid in diagnosing and monitoring this widespread liver disease.

Area of Science:

  • Hepatitis C virus (HCV) detection
  • Electrochemical biosensors
  • Viral diagnostics

Background:

  • Hepatitis C is a significant global liver disease caused by the hepatitis C virus (HCV), affecting an estimated 150 million people worldwide.
  • HCV exhibits high genetic variability, with six major genotypes and 15 subtypes, complicating diagnosis and treatment.
  • Current diagnostic methods include antibody tests, viral load assays, genotyping, and liver biopsy, highlighting the need for advanced detection technologies.

Purpose of the Study:

  • To review current electrochemical immunosensor and genosensor technologies for hepatitis C virus (HCV) detection.
  • To assess the potential of electrochemical biosensors for clinical applications in viral infections.
  • To highlight the need for rapid, sensitive, and robust diagnostic devices for HCV.

Main Methods:

  • Review of existing literature on electrochemical immunosensors and genosensors for HCV detection.
  • Analysis of the principles and applications of electrochemical biosensor technologies in virology.
  • Evaluation of the performance characteristics of reported HCV detection devices.

Main Results:

  • Limited publications currently exist on electrochemical biosensors for HCV detection.
  • Electrochemical biosensors demonstrate potential for sensitive, specific, and reliable HCV detection.
  • These devices offer advantages in terms of simplicity and cost-effectiveness.

Conclusions:

  • Electrochemical biosensors represent a promising technology for the diagnosis and monitoring of hepatitis C virus (HCV) infection.
  • Further research and development are needed to fully realize the clinical potential of these devices.
  • Electrochemical biosensors could significantly improve the management of viral infections, including HCV.